CAS 1620574-24-4

DLK-IN-1

CAS : 1620574-24-4

DLK-IN-1 is a synthetic small-molecule inhibitor, which is a product derived from targeted chemical synthesis with the specific aim of modulating the function of certain kinases. This inhibitor is sourced through advanced laboratory techniques that allow for precision-targeting of proteins involved in cellular signaling pathways. DLK-IN-1 specifically inhibits the dual leucine zipper kinase (DLK), a protein kinase involved in neuronal regeneration and degeneration pathways. By binding to the ATP-binding site of DLK, it prevents the phosphorylation of downstream substrates, thus modulating the DLK-mediated signaling cascade.

Formule : C₂₀H₂₄F₃N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 423.4 g/mol

Ref: 3D-VPC57424

DLK-IN-1

CAS : 1620574-24-4

DLK-IN-1: Oral DLK (MAP3K12) inhibitor, Ki=3nM, effective in Alzheimer's model, CNS permeable, well-tolerated with sustained brain levels.

Formule : C₂₀H₂₄F₃N₅O₂

Couleur et forme : Solid

Masse moléculaire : 423.43

Ref: TM-T11056